SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 4:15 PM ETAbout this dataData status
$27.63▼-0.84 (-2.97%)
After Hours:$27.63+0.00 (+0.00%)· 4:15 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.4 · elevated volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

Deferred Revenue

$13.54M

Quarterly · Period ending: · USD

PBLS logo

PBLS Deferred Revenue

Latest reported$0.00
PBLS FY Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

What is deferred revenue?

Revenue received but not yet earned.

PBLS deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Parabilis Medicines, Inc. Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
0
0

Frequently asked questions: PBLS deferred revenue

What is Parabilis Medicines, Inc. (PBLS)'s current deferred revenue?

Parabilis Medicines, Inc. (PBLS)'s latest reported deferred revenue (Quarterly) is $13.54M as of Sep 30, 2026. Revenue received but not yet earned.

How much historical deferred revenue data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s deferred revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's deferred revenue to peers or set an alert?

You can open PBLS's deferred revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.